Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded
- Contract number
- SPE2DR26F3DS0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,250
Award facts
- Contract value 100% obligated
- $13,250.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 14, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) in 3 mL vials, with a ceiling value of $13,250.22 and a firm fixed price structure. The contract represents a non-set-aside competitive award with an ultimate completion date of November 17, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through competitive procurement, with delivery orders historically ranging from small-value transactions to substantial orders exceeding $45,000. The DLA anticipates establishing multiple regional Pharmaceutical Prime Vendor Global Program Generation V contracts, positioning AmerisourceBergen to continue serving as a strategic supplier within the military's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26F3DS0?
SPE2DR26F3DS0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 14, 2025.
How much is contract SPE2DR26F3DS0 worth?
The government has obligated $13,250 on SPE2DR26F3DS0.
Is contract SPE2DR26F3DS0 an order under another contract?
Yes. SPE2DR26F3DS0 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3DS0 competed?
The extent of competition for SPE2DR26F3DS0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award